Global Prenatal Cell-Free DNA Screening Market Insights, Forecast to 2030

Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Prenatal Cell-Free DNA Screening Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
        1.2.2 Combined First Trimester Screening
        1.2.3 Second Trimester Maternal Serum Screening
    1.3 Market by Application
        1.3.1 Global Prenatal Cell-Free DNA Screening Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
        1.3.2 Diagnostic Laboratories
        1.3.3 Hospitals
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Prenatal Cell-Free DNA Screening Market Perspective (2019-2030)
    2.2 Global Prenatal Cell-Free DNA Screening Growth Trends by Region
        2.2.1 Prenatal Cell-Free DNA Screening Market Size by Region: 2019 VS 2023 VS 2030
        2.2.2 Prenatal Cell-Free DNA Screening Historic Market Size by Region (2019-2024)
        2.2.3 Prenatal Cell-Free DNA Screening Forecasted Market Size by Region (2025-2030)
    2.3 Prenatal Cell-Free DNA Screening Market Dynamics
        2.3.1 Prenatal Cell-Free DNA Screening Industry Trends
        2.3.2 Prenatal Cell-Free DNA Screening Market Drivers
        2.3.3 Prenatal Cell-Free DNA Screening Market Challenges
        2.3.4 Prenatal Cell-Free DNA Screening Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Revenue Prenatal Cell-Free DNA Screening by Players
        3.1.1 Global Prenatal Cell-Free DNA Screening Revenue by Players (2019-2024)
        3.1.2 Global Prenatal Cell-Free DNA Screening Revenue Market Share by Players (2019-2024)
    3.2 Global Prenatal Cell-Free DNA Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Global Key Players of Prenatal Cell-Free DNA Screening, Ranking by Revenue, 2022 VS 2023 VS 2024
    3.4 Global Prenatal Cell-Free DNA Screening Market Concentration Ratio
        3.4.1 Global Prenatal Cell-Free DNA Screening Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Prenatal Cell-Free DNA Screening Revenue in 2023
    3.5 Global Key Players of Prenatal Cell-Free DNA Screening Head office and Area Served
    3.6 Global Key Players of Prenatal Cell-Free DNA Screening, Product and Application
    3.7 Global Key Players of Prenatal Cell-Free DNA Screening, Date of Enter into This Industry
    3.8 Mergers & Acquisitions, Expansion Plans

4 Prenatal Cell-Free DNA Screening Breakdown Data by Type
    4.1 Global Prenatal Cell-Free DNA Screening Historic Market Size by Type (2019-2024)
    4.2 Global Prenatal Cell-Free DNA Screening Forecasted Market Size by Type (2025-2030)

5 Prenatal Cell-Free DNA Screening Breakdown Data by Application
    5.1 Global Prenatal Cell-Free DNA Screening Historic Market Size by Application (2019-2024)
    5.2 Global Prenatal Cell-Free DNA Screening Forecasted Market Size by Application (2025-2030)

6 North America
    6.1 North America Prenatal Cell-Free DNA Screening Market Size (2019-2030)
    6.2 North America Prenatal Cell-Free DNA Screening Market Size by Type
        6.2.1 North America Prenatal Cell-Free DNA Screening Market Size by Type (2019-2024)
        6.2.2 North America Prenatal Cell-Free DNA Screening Market Size by Type (2025-2030)
        6.2.3 North America Prenatal Cell-Free DNA Screening Market Share by Type (2019-2030)
    6.3 North America Prenatal Cell-Free DNA Screening Market Size by Application
        6.3.1 North America Prenatal Cell-Free DNA Screening Market Size by Application (2019-2024)
        6.3.2 North America Prenatal Cell-Free DNA Screening Market Size by Application (2025-2030)
        6.3.3 North America Prenatal Cell-Free DNA Screening Market Share by Application (2019-2030)
    6.4 North America Prenatal Cell-Free DNA Screening Market Size by Country
        6.4.1 North America Prenatal Cell-Free DNA Screening Market Size by Country: 2019 VS 2023 VS 2030
        6.4.2 North America Prenatal Cell-Free DNA Screening Market Size by Country (2019-2024)
        6.4.3 North America Prenatal Cell-Free DNA Screening Market Size by Country (2025-2030)
        6.4.4 United States
        6.4.5 Canada

7 Europe
    7.1 Europe Prenatal Cell-Free DNA Screening Market Size (2019-2030)
    7.2 Europe Prenatal Cell-Free DNA Screening Market Size by Type
        7.2.1 Europe Prenatal Cell-Free DNA Screening Market Size by Type (2019-2024)
        7.2.2 Europe Prenatal Cell-Free DNA Screening Market Size by Type (2025-2030)
        7.2.3 Europe Prenatal Cell-Free DNA Screening Market Share by Type (2019-2030)
    7.3 Europe Prenatal Cell-Free DNA Screening Market Size by Application
        7.3.1 Europe Prenatal Cell-Free DNA Screening Market Size by Application (2019-2024)
        7.3.2 Europe Prenatal Cell-Free DNA Screening Market Size by Application (2025-2030)
        7.3.3 Europe Prenatal Cell-Free DNA Screening Market Share by Application (2019-2030)
    7.4 Europe Prenatal Cell-Free DNA Screening Market Size by Country
        7.4.1 Europe Prenatal Cell-Free DNA Screening Market Size by Country: 2019 VS 2023 VS 2030
        7.4.2 Europe Prenatal Cell-Free DNA Screening Market Size by Country (2019-2024)
        7.4.3 Europe Prenatal Cell-Free DNA Screening Market Size by Country (2025-2030)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic Countries

8 China
    8.1 China Prenatal Cell-Free DNA Screening Market Size (2019-2030)
    8.2 China Prenatal Cell-Free DNA Screening Market Size by Type
        8.2.1 China Prenatal Cell-Free DNA Screening Market Size by Type (2019-2024)
        8.2.2 China Prenatal Cell-Free DNA Screening Market Size by Type (2025-2030)
        8.2.3 China Prenatal Cell-Free DNA Screening Market Share by Type (2019-2030)
    8.3 China Prenatal Cell-Free DNA Screening Market Size by Application
        8.3.1 China Prenatal Cell-Free DNA Screening Market Size by Application (2019-2024)
        8.3.2 China Prenatal Cell-Free DNA Screening Market Size by Application (2025-2030)
        8.3.3 China Prenatal Cell-Free DNA Screening Market Share by Application (2019-2030)

9 Asia (excluding China)
    9.1 Asia Prenatal Cell-Free DNA Screening Market Size (2019-2030)
    9.2 Asia Prenatal Cell-Free DNA Screening Market Size by Type
        9.2.1 Asia Prenatal Cell-Free DNA Screening Market Size by Type (2019-2024)
        9.2.2 Asia Prenatal Cell-Free DNA Screening Market Size by Type (2025-2030)
        9.2.3 Asia Prenatal Cell-Free DNA Screening Market Share by Type (2019-2030)
    9.3 Asia Prenatal Cell-Free DNA Screening Market Size by Application
        9.3.1 Asia Prenatal Cell-Free DNA Screening Market Size by Application (2019-2024)
        9.3.2 Asia Prenatal Cell-Free DNA Screening Market Size by Application (2025-2030)
        9.3.3 Asia Prenatal Cell-Free DNA Screening Market Share by Application (2019-2030)
    9.4 Asia Prenatal Cell-Free DNA Screening Market Size by Region
        9.4.1 Asia Prenatal Cell-Free DNA Screening Market Size by Region: 2019 VS 2023 VS 2030
        9.4.2 Asia Prenatal Cell-Free DNA Screening Market Size by Region (2019-2024)
        9.4.3 Asia Prenatal Cell-Free DNA Screening Market Size by Region (2025-2030)
        9.4.4 Japan
        9.4.5 South Korea
        9.4.6 China Taiwan
        9.4.7 Southeast Asia
        9.4.8 India
        9.4.9 Australia

10 Middle East, Africa, and Latin America
    10.1 Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size (2019-2030)
    10.2 Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Type
        10.2.1 Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Type (2019-2024)
        10.2.2 Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Type (2025-2030)
        10.2.3 Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Share by Type (2019-2030)
    10.3 Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Application
        10.3.1 Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Application (2019-2024)
        10.3.2 Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Application (2025-2030)
        10.3.3 Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Share by Application (2019-2030)
    10.4 Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Country
        10.4.1 Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Country: 2019 VS 2023 VS 2030
        10.4.2 Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Country (2019-2024)
        10.4.3 Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Country (2025-2030)
        10.4.4 Brazil
        10.4.5 Mexico
        10.4.6 Turkey
        10.4.7 Saudi Arabia
        10.4.8 Israel
        10.4.9 GCC Countries

11 Key Players Profiles
    11.1 Yourgene Health
        11.1.1 Yourgene Health Company Details
        11.1.2 Yourgene Health Business Overview
        11.1.3 Yourgene Health Prenatal Cell-Free DNA Screening Introduction
        11.1.4 Yourgene Health Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024)
        11.1.5 Yourgene Health Recent Developments
    11.2 Illumina Inc
        11.2.1 Illumina Inc Company Details
        11.2.2 Illumina Inc Business Overview
        11.2.3 Illumina Inc Prenatal Cell-Free DNA Screening Introduction
        11.2.4 Illumina Inc Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024)
        11.2.5 Illumina Inc Recent Developments
    11.3 Agilent Technologies Inc
        11.3.1 Agilent Technologies Inc Company Details
        11.3.2 Agilent Technologies Inc Business Overview
        11.3.3 Agilent Technologies Inc Prenatal Cell-Free DNA Screening Introduction
        11.3.4 Agilent Technologies Inc Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024)
        11.3.5 Agilent Technologies Inc Recent Developments
    11.4 Thermo Fisher Scientific Inc
        11.4.1 Thermo Fisher Scientific Inc Company Details
        11.4.2 Thermo Fisher Scientific Inc Business Overview
        11.4.3 Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Introduction
        11.4.4 Thermo Fisher Scientific Inc Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024)
        11.4.5 Thermo Fisher Scientific Inc Recent Developments
    11.5 Hoffmann-La Roche Ltd
        11.5.1 Hoffmann-La Roche Ltd Company Details
        11.5.2 Hoffmann-La Roche Ltd Business Overview
        11.5.3 Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Introduction
        11.5.4 Hoffmann-La Roche Ltd Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024)
        11.5.5 Hoffmann-La Roche Ltd Recent Developments
    11.6 Laboratory Corporation of America Holdings
        11.6.1 Laboratory Corporation of America Holdings Company Details
        11.6.2 Laboratory Corporation of America Holdings Business Overview
        11.6.3 Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Introduction
        11.6.4 Laboratory Corporation of America Holdings Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024)
        11.6.5 Laboratory Corporation of America Holdings Recent Developments
    11.7 GE Healthcare
        11.7.1 GE Healthcare Company Details
        11.7.2 GE Healthcare Business Overview
        11.7.3 GE Healthcare Prenatal Cell-Free DNA Screening Introduction
        11.7.4 GE Healthcare Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024)
        11.7.5 GE Healthcare Recent Developments
    11.8 PerkinElmer Inc
        11.8.1 PerkinElmer Inc Company Details
        11.8.2 PerkinElmer Inc Business Overview
        11.8.3 PerkinElmer Inc Prenatal Cell-Free DNA Screening Introduction
        11.8.4 PerkinElmer Inc Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024)
        11.8.5 PerkinElmer Inc Recent Developments
    11.9 BGI
        11.9.1 BGI Company Details
        11.9.2 BGI Business Overview
        11.9.3 BGI Prenatal Cell-Free DNA Screening Introduction
        11.9.4 BGI Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024)
        11.9.5 BGI Recent Developments
    11.10 Natera Inc
        11.10.1 Natera Inc Company Details
        11.10.2 Natera Inc Business Overview
        11.10.3 Natera Inc Prenatal Cell-Free DNA Screening Introduction
        11.10.4 Natera Inc Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024)
        11.10.5 Natera Inc Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

Table of Figures

List of Tables
    Table 1. Global Prenatal Cell-Free DNA Screening Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Combined First Trimester Screening
    Table 3. Key Players of Second Trimester Maternal Serum Screening
    Table 4. Global Prenatal Cell-Free DNA Screening Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 5. Global Prenatal Cell-Free DNA Screening Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Prenatal Cell-Free DNA Screening Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Prenatal Cell-Free DNA Screening Market Share by Region (2019-2024)
    Table 8. Global Prenatal Cell-Free DNA Screening Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Prenatal Cell-Free DNA Screening Market Share by Region (2025-2030)
    Table 10. Prenatal Cell-Free DNA Screening Market Trends
    Table 11. Prenatal Cell-Free DNA Screening Market Drivers
    Table 12. Prenatal Cell-Free DNA Screening Market Challenges
    Table 13. Prenatal Cell-Free DNA Screening Market Restraints
    Table 14. Global Prenatal Cell-Free DNA Screening Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Prenatal Cell-Free DNA Screening Revenue Share by Players (2019-2024)
    Table 16. Global Top Prenatal Cell-Free DNA Screening by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal Cell-Free DNA Screening as of 2023)
    Table 17. Global Prenatal Cell-Free DNA Screening Industry Ranking 2022 VS 2023 VS 2024
    Table 18. Global 5 Largest Players Market Share by Prenatal Cell-Free DNA Screening Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Global Key Players of Prenatal Cell-Free DNA Screening, Headquarters and Area Served
    Table 20. Global Key Players of Prenatal Cell-Free DNA Screening, Product and Application
    Table 21. Global Key Players of Prenatal Cell-Free DNA Screening, Product and Application
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Prenatal Cell-Free DNA Screening Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Type (2019-2024)
    Table 25. Global Prenatal Cell-Free DNA Screening Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Prenatal Cell-Free DNA Screening Revenue Market Share by Type (2025-2030)
    Table 27. Global Prenatal Cell-Free DNA Screening Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Prenatal Cell-Free DNA Screening Revenue Share by Application (2019-2024)
    Table 29. Global Prenatal Cell-Free DNA Screening Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Prenatal Cell-Free DNA Screening Revenue Share by Application (2025-2030)
    Table 31. North America Prenatal Cell-Free DNA Screening Market Size by Type (2019-2024) & (US$ Million)
    Table 32. North America Prenatal Cell-Free DNA Screening Market Size by Type (2025-2030) & (US$ Million)
    Table 33. North America Prenatal Cell-Free DNA Screening Market Size by Application (2019-2024) & (US$ Million)
    Table 34. North America Prenatal Cell-Free DNA Screening Market Size by Application (2025-2030) & (US$ Million)
    Table 35. North America Prenatal Cell-Free DNA Screening Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 36. North America Prenatal Cell-Free DNA Screening Market Size by Country (2019-2024) & (US$ Million)
    Table 37. North America Prenatal Cell-Free DNA Screening Market Size by Country (2025-2030) & (US$ Million)
    Table 38. Europe Prenatal Cell-Free DNA Screening Market Size by Type (2019-2024) & (US$ Million)
    Table 39. Europe Prenatal Cell-Free DNA Screening Market Size by Type (2025-2030) & (US$ Million)
    Table 40. Europe Prenatal Cell-Free DNA Screening Market Size by Application (2019-2024) & (US$ Million)
    Table 41. Europe Prenatal Cell-Free DNA Screening Market Size by Application (2025-2030) & (US$ Million)
    Table 42. Europe Prenatal Cell-Free DNA Screening Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 43. Europe Prenatal Cell-Free DNA Screening Market Size by Country (2019-2024) & (US$ Million)
    Table 44. Europe Prenatal Cell-Free DNA Screening Market Size by Country (2025-2030) & (US$ Million)
    Table 45. China Prenatal Cell-Free DNA Screening Market Size by Type (2019-2024) & (US$ Million)
    Table 46. China Prenatal Cell-Free DNA Screening Market Size by Type (2025-2030) & (US$ Million)
    Table 47. China Prenatal Cell-Free DNA Screening Market Size by Application (2019-2024) & (US$ Million)
    Table 48. China Prenatal Cell-Free DNA Screening Market Size by Application (2025-2030) & (US$ Million)
    Table 49. Asia Prenatal Cell-Free DNA Screening Market Size by Type (2019-2024) & (US$ Million)
    Table 50. Asia Prenatal Cell-Free DNA Screening Market Size by Type (2025-2030) & (US$ Million)
    Table 51. Asia Prenatal Cell-Free DNA Screening Market Size by Application (2019-2024) & (US$ Million)
    Table 52. Asia Prenatal Cell-Free DNA Screening Market Size by Application (2025-2030) & (US$ Million)
    Table 53. Asia Prenatal Cell-Free DNA Screening Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 54. Asia Prenatal Cell-Free DNA Screening Market Size by Region (2019-2024) & (US$ Million)
    Table 55. Asia Prenatal Cell-Free DNA Screening Market Size by Region (2025-2030) & (US$ Million)
    Table 56. Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Type (2019-2024) & (US$ Million)
    Table 57. Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Type (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Application (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Application (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 61. Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Country (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size by Country (2025-2030) & (US$ Million)
    Table 63. Yourgene Health Company Details
    Table 64. Yourgene Health Business Overview
    Table 65. Yourgene Health Prenatal Cell-Free DNA Screening Product
    Table 66. Yourgene Health Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024) & (US$ Million)
    Table 67. Yourgene Health Recent Developments
    Table 68. Illumina Inc Company Details
    Table 69. Illumina Inc Business Overview
    Table 70. Illumina Inc Prenatal Cell-Free DNA Screening Product
    Table 71. Illumina Inc Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024) & (US$ Million)
    Table 72. Illumina Inc Recent Developments
    Table 73. Agilent Technologies Inc Company Details
    Table 74. Agilent Technologies Inc Business Overview
    Table 75. Agilent Technologies Inc Prenatal Cell-Free DNA Screening Product
    Table 76. Agilent Technologies Inc Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024) & (US$ Million)
    Table 77. Agilent Technologies Inc Recent Developments
    Table 78. Thermo Fisher Scientific Inc Company Details
    Table 79. Thermo Fisher Scientific Inc Business Overview
    Table 80. Thermo Fisher Scientific Inc Prenatal Cell-Free DNA Screening Product
    Table 81. Thermo Fisher Scientific Inc Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024) & (US$ Million)
    Table 82. Thermo Fisher Scientific Inc Recent Developments
    Table 83. Hoffmann-La Roche Ltd Company Details
    Table 84. Hoffmann-La Roche Ltd Business Overview
    Table 85. Hoffmann-La Roche Ltd Prenatal Cell-Free DNA Screening Product
    Table 86. Hoffmann-La Roche Ltd Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024) & (US$ Million)
    Table 87. Hoffmann-La Roche Ltd Recent Developments
    Table 88. Laboratory Corporation of America Holdings Company Details
    Table 89. Laboratory Corporation of America Holdings Business Overview
    Table 90. Laboratory Corporation of America Holdings Prenatal Cell-Free DNA Screening Product
    Table 91. Laboratory Corporation of America Holdings Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024) & (US$ Million)
    Table 92. Laboratory Corporation of America Holdings Recent Developments
    Table 93. GE Healthcare Company Details
    Table 94. GE Healthcare Business Overview
    Table 95. GE Healthcare Prenatal Cell-Free DNA Screening Product
    Table 96. GE Healthcare Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024) & (US$ Million)
    Table 97. GE Healthcare Recent Developments
    Table 98. PerkinElmer Inc Company Details
    Table 99. PerkinElmer Inc Business Overview
    Table 100. PerkinElmer Inc Prenatal Cell-Free DNA Screening Product
    Table 101. PerkinElmer Inc Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024) & (US$ Million)
    Table 102. PerkinElmer Inc Recent Developments
    Table 103. BGI Company Details
    Table 104. BGI Business Overview
    Table 105. BGI Prenatal Cell-Free DNA Screening Product
    Table 106. BGI Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024) & (US$ Million)
    Table 107. BGI Recent Developments
    Table 108. Natera Inc Company Details
    Table 109. Natera Inc Business Overview
    Table 110. Natera Inc Prenatal Cell-Free DNA Screening Product
    Table 111. Natera Inc Revenue in Prenatal Cell-Free DNA Screening Business (2019-2024) & (US$ Million)
    Table 112. Natera Inc Recent Developments
    Table 113. Research Programs/Design for This Report
    Table 114. Key Data Information from Secondary Sources
    Table 115. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Prenatal Cell-Free DNA Screening Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Prenatal Cell-Free DNA Screening Market Share by Type: 2023 VS 2030
    Figure 3. Combined First Trimester Screening Features
    Figure 4. Second Trimester Maternal Serum Screening Features
    Figure 5. Global Prenatal Cell-Free DNA Screening Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 6. Global Prenatal Cell-Free DNA Screening Market Share by Application: 2023 VS 2030
    Figure 7. Diagnostic Laboratories Case Studies
    Figure 8. Hospitals Case Studies
    Figure 9. Prenatal Cell-Free DNA Screening Report Years Considered
    Figure 10. Global Prenatal Cell-Free DNA Screening Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 11. Global Prenatal Cell-Free DNA Screening Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 12. Global Prenatal Cell-Free DNA Screening Market Share by Region: 2023 VS 2030
    Figure 13. Global Prenatal Cell-Free DNA Screening Market Share by Players in 2023
    Figure 14. Global Top Prenatal Cell-Free DNA Screening Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prenatal Cell-Free DNA Screening as of 2023)
    Figure 15. The Top 10 and 5 Players Market Share by Prenatal Cell-Free DNA Screening Revenue in 2023
    Figure 16. North America Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 17. North America Prenatal Cell-Free DNA Screening Market Share by Type (2019-2030)
    Figure 18. North America Prenatal Cell-Free DNA Screening Market Share by Application (2019-2030)
    Figure 19. North America Prenatal Cell-Free DNA Screening Market Share by Country (2019-2030)
    Figure 20. United States Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Prenatal Cell-Free DNA Screening Market Size YoY (2019-2030) & (US$ Million)
    Figure 23. Europe Prenatal Cell-Free DNA Screening Market Share by Type (2019-2030)
    Figure 24. Europe Prenatal Cell-Free DNA Screening Market Share by Application (2019-2030)
    Figure 25. Europe Prenatal Cell-Free DNA Screening Market Share by Country (2019-2030)
    Figure 26. Germany Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. France Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. U.K. Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Italy Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Russia Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Nordic Countries Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. China Prenatal Cell-Free DNA Screening Market Size YoY (2019-2030) & (US$ Million)
    Figure 33. China Prenatal Cell-Free DNA Screening Market Share by Type (2019-2030)
    Figure 34. China Prenatal Cell-Free DNA Screening Market Share by Application (2019-2030)
    Figure 35. Asia Prenatal Cell-Free DNA Screening Market Size YoY (2019-2030) & (US$ Million)
    Figure 36. Asia Prenatal Cell-Free DNA Screening Market Share by Type (2019-2030)
    Figure 37. Asia Prenatal Cell-Free DNA Screening Market Share by Application (2019-2030)
    Figure 38. Asia Prenatal Cell-Free DNA Screening Market Share by Region (2019-2030)
    Figure 39. Japan Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 40. South Korea Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. China Taiwan Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Southeast Asia Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. India Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. Australia Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Size YoY (2019-2030) & (US$ Million)
    Figure 46. Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Share by Type (2019-2030)
    Figure 47. Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Share by Application (2019-2030)
    Figure 48. Middle East, Africa, and Latin America Prenatal Cell-Free DNA Screening Market Share by Country (2019-2030)
    Figure 49. Brazil Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Mexico Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Turkey Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 53. Israel Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. GCC Countries Prenatal Cell-Free DNA Screening Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Yourgene Health Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2019-2024)
    Figure 56. Illumina Inc Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2019-2024)
    Figure 57. Agilent Technologies Inc Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2019-2024)
    Figure 58. Thermo Fisher Scientific Inc Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2019-2024)
    Figure 59. Hoffmann-La Roche Ltd Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2019-2024)
    Figure 60. Laboratory Corporation of America Holdings Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2019-2024)
    Figure 61. GE Healthcare Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2019-2024)
    Figure 62. PerkinElmer Inc Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2019-2024)
    Figure 63. BGI Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2019-2024)
    Figure 64. Natera Inc Revenue Growth Rate in Prenatal Cell-Free DNA Screening Business (2019-2024)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed

Related Reports

• 

  Prenatal Cell-Free DNA Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

  The global market for Prenatal Cell-Free DNA Screening was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

  

  Published: 2024-01-13

  

  Pages: 110

  USD 3950.00

  (Single User License)

• 

  Global Prenatal Cell-Free DNA Screening Market Research Report 2025

  The global market for Prenatal Cell-Free DNA Screening was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

  

  Published: 2025-03-03

  

  Pages: 72

  USD 2900.00

  (Single User License)

• 

  Prenatal Cell-Free DNA Screening- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

  The global market for Prenatal Cell-Free DNA Screening was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

  

  Published: 2025-03-03

  

  Pages: 94

  USD 3950.00

  (Single User License)

• 

  Global Prenatal Cell-Free DNA Screening Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

  The global Prenatal Cell-Free DNA Screening market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

  

  Published: 2025-09-06

  

  Pages: 80

  USD 4250.00

  (Single User License)

• 

  Global Prenatal Cell-Free DNA Screening Market Outlook, In‑Depth Analysis & Forecast to 2031

  The global Prenatal Cell-Free DNA Screening market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.

  

  Published: 2025-10-03

  

  Pages: 128

  USD 4900.00

  (Single User License)

• 

  Prenatal Cell-Free DNA Screening - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

  The global market for Prenatal Cell-Free DNA Screening was estimated to be worth US$ 772 million in 2025 and is projected to reach US$ 1420 million, growing at a CAGR of 9.2% from 2026 to 2032.

  

  Published: 2026-03-08

  

  Pages: 131

  USD 3950.00

  (Single User License)

• 

  Global Prenatal Cell-Free DNA Screening Market Research Report 2026

  The global Prenatal Cell-Free DNA Screening market was valued at US$ 772 million in 2025 and is anticipated to reach US$ 1420 million by 2032, at a CAGR of 9.2% from 2026 to 2032.

  

  Published: 2026-03-08

  

  Pages: 128

  USD 2900.00

  (Single User License)

• 

  Global Prenatal Cell-Free DNA Screening Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032

  The global Prenatal Cell-Free DNA Screening market size was US$ 772 million in 2025 and is forecast to reach a readjusted size of US$ 1420 million by 2032 with a CAGR of 9.2% during the forecast period 2026-2032.

  

  Published: 2026-03-08

  

  Pages: 105

  USD 4250.00

  (Single User License)

• 

  Global Prenatal Cell-Free DNA Screening Market Outlook, In‑Depth Analysis & Forecast to 2032

  The global Prenatal Cell-Free DNA Screening market is projected to grow from US$ 772 million in 2025 to US$ 1420 million by 2032, at a CAGR of 9.2% (2026-2032), driven by critical product segments and diverse end‑use applications.

  

  Published: 2026-03-08

  

  Pages: 157

  USD 4900.00

  (Single User License)